Aeglea: Q2 Earnings Snapshot

August 4, 2022 GMT

AUSTIN, Texas (AP) _ Aeglea Biotherapeutics Inc. (AGLE) on Thursday reported a loss of $22.3 million in its second quarter.

On a per-share basis, the Austin, Texas-based company said it had a loss of 27 cents.

The biopharmaceutical company posted revenue of $625,000 in the period.

The company’s shares closed at 39 cents. A year ago, they were trading at $6.27.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on AGLE at